Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bilirubin infusion during human endotoxemia
NL-OMON35603Withdrawn
- Sponsor
- Radboud University Medical Center
- Start
- Oct 2011
- Countries
- 1
01
Overview
Open-label trial in sepsis (3 arms), sponsored by Radboud University Medical Center. Primary endpoint: Circulating cytokine concentrations after LPS administration. Planned start Oct 2011; status: withdrawn.
02
Conditions
sepsis
Beyond the preview
Go deeper on NL-OMON35603.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON35603.